1-Phenylisatin → 3-[(2-Methyl-1,3-benzothiazol-5-YL)imino]-1-phenyl-1,3-dihydro-2H-indol-2-one

HRID 218107

反応式

HRID 218107 の反応式
[NH2:1][C:2]1[CH:3]=[CH:4][C:5]2[S:9][C:8]([CH3:10])=[N:7][C:6]=2[CH:11]=1.[C:12]1([N:18]2[C:28]3[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=3)[C:21](=O)[C:19]2=[O:20])[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=1>>[CH3:10][C:8]1[S:9][C:5]2[CH:4]=[CH:3][C:2]([N:1]=[C:21]3[C:23]4[C:28](=[CH:27][CH:26]=[CH:25][CH:24]=4)[N:18]([C:12]4[CH:13]=[CH:14][CH:15]=[CH:16][CH:17]=4)[C:19]3=[O:20])=[CH:11][C:6]=2[N:7]=1

参加物

3

反応物 2

HCID 128841-PhenylisatinHCID 362295-Benzothiazolamine, 2-methyl-

生成物 1

HCID 99991623-[(2-Methyl-1,3-benzothiazol-5-YL)imino]-1-phenyl-1,3-dihydro-2H-indol-2-one収率 32.3%

反応条件

温度
140 °C

実験手順

5-amino-2-methylbenzothiazole (52.2 mg, 0.31 mmol) was mixed with 1-phenylisatin (69.7 mg, 0.31 mmol) and heated at 140° C. for 3 h. The resulting crude product was purified by preparative TLC using ethyl acetate/hexane (6:4) as the eluent to give the desired product as a yellow solid (36.9 mg, 32.3%). 1H NMR Data: δ 7.9-6.7 (m, 12H), 2.9 (s, 3H). ESI-MS m/z found 370 (MH+).

後処理

  1. customThe resulting crude product was purified by preparative TLC

出典と根拠

ORDレコード
ord-afffb651d6684f8eadacbd9dae55f26a
出典データセット
uspto-grants-2012_06
特許番号
US08198313B2

関連ノート

読み込み中…